Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures

/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...

Related Keywords

Brian Kotzin ,Biopartners Westlake ,Iconovir Bio ,Chris Liu ,Fred Cohen ,Danielk Spiegelman ,Mark Genovese ,Ian Clark ,Dominic Borie ,Desmond Padhi ,Beth Seidenberg ,Heba Nowyhed ,Ishaan Gandhi ,Gilead Sciences ,Gilead Company ,Genentech ,Nektar Therapeutics ,National Institutes Of Health ,Tizona Therapeutics Inc ,Rigel Pharmaceuticals ,Westlake Village Biopartners ,Vida Ventures ,Insight Partners ,Intellia Therapeutics ,Argentum Peak ,Hudson Bay Capital ,National Institutes ,Regt Cell ,Northpond Ventures ,Tizona Therapeutics ,Myriad Genetics ,Spruce Biosciences ,Kyverna Therapeutics ,